Emerge Weight Loss Review

Four weeks is not a month, and this is where it costs you

The pricing page has a FAQ entry asking how much compounded tirzepatide costs per month. The answer begins: plans are billed every four weeks. Then it lists four doses with four figures, all on that four-week cycle.

A four-week cycle is thirteen billing events in a year. A monthly cycle is twelve. So a reader who takes the starter figure, multiplies by twelve and budgets accordingly will be one full payment short at the end of the first year — and the size of that shortfall is exactly the starter figure itself. Nothing on the page does that arithmetic, and nothing on the page warns that it needs doing.

Our rows carry these figures marked as not monthly, precisely so no page on this site can print a slash-mo suffix beside them. That is not a stylistic choice: a template that appends the wrong unit contradicts its own qualifier in the same line, on a page whose entire purpose is comparing prices.

The strange part is that Emerge already knows how to say per month. Its oral tablet page says it twice — that the plans are monthly, and that all prices are per month — with a thirty-tablet supply named as what the figure buys. So one seller runs two products on two different billing cycles and does not mention it on either page.

The ladder is fully published, which almost nothing here manages

Most sellers on this roster publish a starting figure and let the dose question resolve itself somewhere inside the intake. Emerge publishes four rungs on the injection with a price on each, then names two higher rungs and says plainly that they are available to existing patients only, adding that many patients never go beyond the fourth.

That last line is worth pausing on. It is a seller volunteering that most people will not need its two most expensive tiers, on the page where it is trying to sell them. It also tells a new patient exactly where their ceiling is on day one.

The oral tablet ladder is published the same way — a starting tier and two higher tiers, each priced, each described as determined by the provider at intake review. One gap: the page states how many tablets the starting tier buys but never states its strength, while both higher tiers are named by milligrams. So the cheapest oral tier is the one rung on this site whose dose you cannot read off the page.

What the figures include is itemised rather than implied: the medicine, the prescription, the syringes, overnight shipping, and medical oversight. The fees question is answered with the word none, followed by the specific fees that do not apply — no signup fee, no separate doctor or consultation fee, no shipping charge.

A named medical director, with a CV

The about page names Sherryl Ashberg, M.D. as medical director and then does something unusual: it backs the name up. Board certification through the American Board of Family Medicine. A family medicine residency at Shands Jacksonville, chief resident, intern of the year. Medical school and year. Professional memberships. A period as a medical officer with a health department in South Africa. A second physician, Marcus Cox, MD, FACC, is named on the same page.

This is what the prescriber question is actually asking for. Not a phrase about board-certified clinicians, and not an advisory board — a person, with credentials specific enough that a reader could look her up in a state licensing database before handing over a card. Several sellers in this comparison name doctors who turn out to be advisors rather than prescribers; this page says she leads the team.

The pharmacy question does not get the same treatment. The tablet page says each tablet is individually compounded through a licensed 503A pharmacy, and the Terms say partnered state-licensed 503A compounding pharmacies. That is a regulatory class, not a company. The FAQ even points readers to what it calls our pharmacy pages for cold-chain temperature data, without naming a pharmacy on any page we read.

It says the awkward things out loud

The Terms carry a section stating that medications prescribed through Emerge, including semaglutide and tirzepatide, may be prescribed off-label — at doses, titration schedules or BMI thresholds outside the FDA-approved labelling for the branded product — and explaining that off-label prescribing is legal and regulated by state medical boards rather than the FDA. Most sellers here leave that unsaid entirely.

The same section states that compounded preparations are not FDA-approved and that the FDA does not review them for safety, effectiveness or quality. Again, plainly, in the document a buyer agrees to.

There is one more figure on the pricing page that we have deliberately kept off our record: a maintenance plan for patients who have reached their goal, charged every four weeks for medical supervision and care-team access, with medication refills billed separately per vial. It is a low number, and it is not a price for treatment. Putting it on our roster would place it at the bottom of a tirzepatide comparison as though it bought the drug, which it explicitly does not.

The one thing it will not tell you is where it works

The FAQ has a question headed states serviced. Its entire answer is that Emerge does not service California, followed by a caveat that because of evolving state requirements and pharmacy limitations, certain medications may not be available in all states at all times.

That is one named exclusion and no list. We searched the homepage, the pricing page, the FAQ, the Terms, the privacy policy, the about page, the programme page, the what-to-expect page and the tablet page for the phrases all fifty states, nationwide, every state and forty-nine states. None of them appears anywhere.

So our row records no states at all. Turning a single named exclusion into a forty-nine-state list would mean inventing the other forty-nine, and a reader in any of the states this seller has never mentioned would be reading a claim nobody made. If you are in California, the answer is published and it is no. Everywhere else, you will find out at intake.

The legal entity is published, at least, and on the pricing page itself rather than buried: Emerge Weight Loss, LLC, with the trademark registration noted beside it, a phone number and an email address.